The Penumbra System consists of large, highly pliable and trackable Reperfusion Catheters that utilize the full aspiration power of the Penumbra Pump MAX™ within an integrated, proprietary system to ...

The Penumbra 3D Trial successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy of the company's next-generation stent retriever, Penumbra 3D ...

Clinical Experience with Penumbra JET™ 7 Reperfusion Catheter with XTRA FLEX Technology to be Highlighted at Company-Sponsored Symposium MIAMI--(BUSINESS WIRE)-- Penumbra, Inc. (NYSE: PEN), a global ...

Now available in the U.S., RED™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...

., announces the launch of an educational website , designed to empower the public with the knowledge they need to help stop stroke. The website asks visitors to “Join the Quest” and learn where to ...

SILVER SPRING, MD — The Penumbra 3D Revascularization device has been recalled because of the potential for the delivery wire to break or separate during use and leave fractured pieces inside a ...

A study led by Achala Vagal, MD, associate professor at the University of Cincinnati (UC) College of Medicine and a UC Health radiologist, looked at a group of untreated acute stroke patients and ...

Short seller Quintessential Capital Management raised concerns over the safety of Penumbra Inc.’s Jet 7 catheter for stroke victims in a new report Tuesday. Shares of the company tumbled in early ...

Penumbra, Inc., a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System's most advanced technology: Penumbra JET 7 and Penumbra ...

Baron and Bousser described the limited blood flow in an ischemic region as 'misery perfusion', as it resulted in electrical silence but preservation of ion homeostasis. [23] Later, Astrup et al.

The company forecasts fiscal year 2025 sales of $1.34 billion-$1.36 billion versus a consensus of $1.36 billion. Penumbra projects the U.S. thrombectomy franchise will grow 19% to 20% year over year, ...